Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Primary peritoneal carcinoma and Fallopian tube cancer to the study conditions, and updated the page to revision v3.4.2.SummaryDifference0.3%

- Check26 days agoChange DetectedA site-wide Notice was added stating a lapse in government funding may delay data updates and affect operations; a Revision: v3.4.1 was added, replacing the previous v3.4.0.SummaryDifference0.2%

- Check33 days agoChange DetectedAdded UI element: Show glossary, and updated the revision label to Revision: v3.4.0. Adjusted QC/FEAR Act wording and capitalization (Last Update... met QC Criteria; No FEAR Act data) to reflect the new version from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry v3.3.4 was added and the previous v3.3.3 entry was removed from the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedLocations were updated to add several new sites (Colorado, Georgia, Ceará, Paraná, Rio Grande do Sul, Santa Catarina, São Paulo, Alberta, Ontario, Quebec, Jihormoravsky KRAJ, Prague, Hajdú-Bihar, West Pomeranian Voivodeship, England, Surrey). It also removes previously listed sites, altering where the study is conducted and how to contact investigators.SummaryDifference1.0%

- Check97 days agoChange DetectedThe PubMed publication text on the study page was updated to indicate publications are automatically filled from PubMed, and the revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.